Literature DB >> 29122918

Recommending prolonged bedaquiline use for the treatment of highly resistant strains of tuberculosis.

Jennifer Furin1, Erica Lessem2, Vivian Cox3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29122918     DOI： 10.1183/13993003.01552-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  2 in total

1.  Prolonged use of bedaquiline in two patients with pulmonary extensively drug-resistant tuberculosis: Two case reports.

Authors:  Jing-Tao Gao; Li Xie; Li-Ping Ma; Wei Shu; Li-Jie Zhang; Yu-Jia Ning; Shi-Heng Xie; Yu-Hong Liu; Meng-Qiu Gao
Journal:  World J Clin Cases       Date:  2021-04-06       Impact factor: 1.337

2.  Effectiveness and Cardiac Safety of Bedaquiline-Based Therapy for Drug-Resistant Tuberculosis: A Prospective Cohort Study.

Authors:  James C M Brust; Neel R Gandhi; Sean Wasserman; Gary Maartens; Shaheed V Omar; Nazir A Ismail; Angela Campbell; Lindsay Joseph; Alexandria Hahn; Salim Allana; Alfonso C Hernandez-Romieu; Chenshu Zhang; Koleka Mlisana; Charle A Viljoen; Benjamin Zalta; Ismaeel Ebrahim; Meghan Franczek; Iqbal Master; Limpho Ramangoaela; Julian Te Riele; Graeme Meintjes
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.